Cabaletta Bio's total assets for Q3 2024 were $204.41M, a decrease of -5.98% from the previous quarter. CABA total liabilities were $30.17M for the fiscal quarter, a 68.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.